These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1001205

  • 1. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH.
    Dtsch Med Wochenschr; 1976 Dec 17; 101(51):1868-71. PubMed ID: 1001205
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
    Koschinsky T, Lenhard P, Gries FA, Vogelberg KH, Wolfram G, Lang PD, Vollmar J.
    Med Klin; 1977 Sep 23; 72(38):1537-43. PubMed ID: 904549
    [Abstract] [Full Text] [Related]

  • 3. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
    Vogelberg KH, Althoff B, Heggen EM, Thesseling W.
    Verh Dtsch Ges Inn Med; 1976 Sep 23; 82 Pt 1():832-5. PubMed ID: 196437
    [No Abstract] [Full Text] [Related]

  • 4. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H.
    MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T, Gries FA, Schwandt P, Weisweiler P, Hansen W, Nijssen J, Beckmann R.
    MMW Munch Med Wochenschr; 1977 May 20; 119(20):701-4. PubMed ID: 195201
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U, Johannes KJ.
    MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1127-30. PubMed ID: 184377
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
    Vogelberg KH, Cicmir I, Heggen ME.
    Arzneimittelforschung; 1980 Sep 03; 30(4):683-5. PubMed ID: 7190412
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].
    Mertz DP, Suermann J.
    Med Klin; 1978 Jun 09; 73(23):867-73. PubMed ID: 207959
    [Abstract] [Full Text] [Related]

  • 14. [The lipid reducing action of phenformin in primary type IV hyperlipoproteinaemia (author's transl)].
    Lang PD, Vollmar J, Klemens UH, von Löwis P, Gries FA, Koschinsky T, Huth K, Pilz E, Schlierf G, Kremer GJ, Lenhart P, Schwandt P, Hammerl H, Studlar M.
    Dtsch Med Wochenschr; 1973 Nov 30; 98(48):2280-6. PubMed ID: 4762828
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G, Keller C, Kilani S, Zöllner N.
    Dtsch Med Wochenschr; 1976 Jan 16; 101(3):76-81. PubMed ID: 1245160
    [Abstract] [Full Text] [Related]

  • 16. [Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].
    Wahl P, Hasslacher C, Lang PD, Vollmar J.
    Dtsch Med Wochenschr; 1978 Aug 04; 103(31):1233-7. PubMed ID: 668570
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of hyperlipoproteinemias (author's transl)].
    Crepaldi G, Fellin R, Briani G, Baggio G, Baiocchi MR.
    G Ital Cardiol; 1974 Aug 04; 4(3):332-40. PubMed ID: 4367439
    [No Abstract] [Full Text] [Related]

  • 18. Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
    Dunnigan MG, Cochrane MA, Kelly A, Scott JW.
    Q J Med; 1974 Jan 04; 43(169):33-48. PubMed ID: 4362786
    [No Abstract] [Full Text] [Related]

  • 19. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
    Hammerl H, Nebosis G, Pichler O, Studlar M.
    Med Welt; 1973 Mar 23; 24(12):468-70. PubMed ID: 4700881
    [No Abstract] [Full Text] [Related]

  • 20. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J, Salonen J, Kuuisto P, Virtamo J, Manninen V, Mälkönen M.
    Proc R Soc Med; 1976 Mar 23; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.